There has been a storm of misinformation on #menopause symptoms and treatment lately. PharmedOut announces a new regular feature "Missing the Mark on Menopause," where we highlight misleading information in the media. #missingthemarkonmenopause

62% of cases of prescription opioid use disorder "are actually among people who use their opioids as prescribed. That’s an estimated 3 million adults experiencing symptoms of opioid use disorder even though they have never misused opioids."

Pfizer to pay $60 million to settle claims that Biohaven paid kickbacks to doctors via @statnews

The Devastating Legacy of Lies in Alzheimer’s Science

Fugh-Berman tells WaPo that its premature to say suzetrigine, a non-opioid analgesic, poses no addiction risk. Gabapentin, used for nerve pain was once though non-addictive but is now considered a drug of abuse.

Giant Companies Took Secret Payments to Allow Free Flow of Opioids

Veozah (fezolinetant), a non-hormonal treatment for menopausal hot flashes, receives black box warning for liver damage.

Excellent interview of Jerome Hoffman by Martha Rosenberg on overdiagnosis via @kevinmd

@garyschwitzer Great article on #menopause in the media. Nanette Santoro: “The faux indignant nonsense is just becoming a pervasive part of our culture where everyone is being wronged by some dunderheaded enemy and getting all fired up to fight back."

The NYT article never mentions adverse effects of  hormones, which include breast cancer, stroke, dementia, gallbladder disease, and incontinence. For more resources on menopauses, visit:

Murray Ross and Tony Barrueta provide a clear and compelling primer on why drug prices are so high

There is no evidence that estrogen prevents #dementia; estrogen-progestin drugs INCREASE risk. In BMJ’s Drugs and Therapeutics Bulletin, Mintzes and Fugh-Berman dissect an error-filled review that claims otherwise. #menopause

Butler and Fugh-Berman: Pharma-funded Alzheimer’s groups lobby against patients' interests with biased poll designed to oppose CMS registry that tracks adverse events of dementia treatments. via @PittsburghPG

At toxicology meeting, FDA reports asthma drug Singulair (montelukast) binds to receptors in the brain; the drug has previously been linked with mental health problems, including suicide

One in five don't lose weight with weight loss drugs.

40% of dementia cases could be prevented or delayed by modifying risk factors. A brain care score rates 12 different risks; a higher score links to lower risk (even in those with family history of dementia.

RT @pharmalot: A documentary about menopause has ‘misinformation’ and shouldn’t be used to educate docs, critics say..

PharmedOut letter demands that Federation of State Medical Boards @TheFSMB remove CME credits from #menopause documentary rife with "misinformation, including statements that directly contradict warnings in FDA-approved product labeling” via @statnews